The Efficacy of Brief Motivational Interviewing for Trauma Patients Related to Alcohol or Other Abuse Drugs. (MOTIVA)

The purpose of this study is to determine whether the Brief Motivational Interview will produce a significantly reduction in risk behavior than usual treatment 3 months after discharge from hospital in people who have survived a traumatism.

Study Overview

Status

Unknown

Detailed Description

Objectives:

  1. To determine the efficacy of Brief Motivational Interview against an usual hospital treatment (no psychological treatment) in patients who have suffered an accident under the influence of drugs (1) to reduce risk behaviors and drug consumption and (2) to increase motivation to change behavior and risk perception.
  2. To investigate the mediating role of impulsive personality and decision making in the impact of Brief Motivational Interview on reduction of risk driving.
  3. To assess the economic viability of the results of Brief Motivational Interview through a cost-utility analysis.

Study Type

Interventional

Enrollment (Anticipated)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Andalucia
      • Granada, Andalucia, Spain, 18000
        • Hospital Virgen de las Nieves

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Trauma patients who have had: 1) A road crash, 2) A sport injury, 3) Occupational accident.
  • Tested positive on alcohol and/or other abuse drugs tests.

Exclusion Criteria:

  • Cognitive or brain-damage that prevent assessment and Brief Motivational Interview
  • Psychopathological disorders
  • Residence status that prevents follow-up (residence outside of Spain, homeless).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Intervention
A standard intervention will be performed by nursing staff during hospital admission. Written information about the consequences of driving under the influence of alcohol and/or drugs will be provided. No psychological intervention.
Experimental: Brief Motivational Interview
A Brief Motivational Interviewing will be performed during hospital admission by a psychologist experienced with this intervention.
The Brief Motivational Interview implies an empathic interviewing style which (i) recognizes, examines and tries to resolve the patient´s ambivalence to facilitate behavioral change, (ii) promotes self-efficacy, (iii) allows flexibility in strategies, including short-term aims to reduce consumption and decrease damage linked to this consumption (like road accidents), (iv) works to reduce the patient's resistances, and (v) provides individualized feedback, if deemed appropriate, to promote recognition of the problem and cognitive restructuring.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk behavior
Time Frame: Baseline, month 3.
Measure with Short Driver Behaviour Questionnaire (SDBQ) and Domain-Specific Risk-Taking (DOSPERT)
Baseline, month 3.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol and Other Drug consumption
Time Frame: Baseline, month 3.
Measure with Timeline Followback (TLFB), Interview for Research on Addictive Behavior (IRAB) and Audit Test.
Baseline, month 3.
Motivation to change
Time Frame: Baseline, post-intervention, month 3
Measure with SOCRATES-8
Baseline, post-intervention, month 3
Risk perception
Time Frame: Baseline, post-intervention, month 3.
Risk perception questionnaire, perceived risk of alcohol and drug (EDADES).
Baseline, post-intervention, month 3.
General Health
Time Frame: Baseline, month 3.
Measure with SF6D
Baseline, month 3.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk Taking and Impulsive Behavior
Time Frame: Baseline, month 3.
Measure with Impulsive Behavior Scale (UPPS-P) and Self-efficacy questionnaire
Baseline, month 3.
Real-life decision making
Time Frame: Baseline, month 3.
Iowa Gambling Task (IGT)
Baseline, month 3.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Raquel Vilar, PhD, Universidad de Granada

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Anticipated)

March 1, 2016

Study Completion (Anticipated)

December 1, 2016

Study Registration Dates

First Submitted

June 6, 2014

First Submitted That Met QC Criteria

June 6, 2014

First Posted (Estimate)

June 9, 2014

Study Record Updates

Last Update Posted (Estimate)

September 25, 2015

Last Update Submitted That Met QC Criteria

September 24, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on AODD and AODR Disorder

Clinical Trials on Brief Motivational Interview

3
Subscribe